SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001144204-14-006928
Filing Date
2014-02-07
Accepted
2014-02-07 16:09:12
Documents
14

Document Format Files

Seq Description Document Type Size
1 F-1 v367497_f1.htm F-1 1437268
2 EXHIBIT 23.1 v367497_ex23-1.htm EX-23.1 2790
3 GRAPHIC slide1.jpg GRAPHIC 145160
4 GRAPHIC slide2.jpg GRAPHIC 87392
5 GRAPHIC tlogo.jpg GRAPHIC 15257
6 GRAPHIC tlogo1.jpg GRAPHIC 6369
7 GRAPHIC tpg131.jpg GRAPHIC 24304
8 GRAPHIC tpg61.jpg GRAPHIC 82294
9 GRAPHIC tpg64.jpg GRAPHIC 83538
10 GRAPHIC tpg65.jpg GRAPHIC 74352
11 GRAPHIC tpg66.jpg GRAPHIC 29532
12 GRAPHIC tpg68.jpg GRAPHIC 160946
13 GRAPHIC tpg69.jpg GRAPHIC 100614
14 GRAPHIC tpg69a.jpg GRAPHIC 82786
  Complete submission text file 0001144204-14-006928.txt   2672229
Mailing Address 35 AHAD HA'AM ST TEL AVIV L3 65202
Business Address 35 AHAD HA'AM ST TEL AVIV L3 65202 972 (0) 3 7326616
BIO BLAST PHARMA LTD. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-193824 | Film No.: 14584436